Universe Pharmaceuticals (UPC) Cash & Current Investments (2020 - 2025)
Universe Pharmaceuticals (UPC) has disclosed Cash & Current Investments for 6 consecutive years, with $70.2 million as the latest value for Q3 2025.
- Quarterly Cash & Current Investments fell 99.77% to $70.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $70.2 million through Sep 2025, down 99.77% year-over-year, with the annual reading at $70.2 million for FY2025, 99.77% down from the prior year.
- Cash & Current Investments hit $70.2 million in Q3 2025 for Universe Pharmaceuticals, down from $30.9 billion in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $30.9 billion in Q3 2024 to a low of $21.8 million in Q3 2021.
- Historically, Cash & Current Investments has averaged $8.4 billion across 5 years, with a median of $5.3 billion in 2023.
- Biggest five-year swings in Cash & Current Investments: skyrocketed 26155.92% in 2022 and later tumbled 99.77% in 2025.
- Year by year, Cash & Current Investments stood at $21.8 million in 2021, then surged by 26155.92% to $5.7 billion in 2022, then fell by 7.65% to $5.3 billion in 2023, then soared by 484.03% to $30.9 billion in 2024, then crashed by 99.77% to $70.2 million in 2025.
- Business Quant data shows Cash & Current Investments for UPC at $70.2 million in Q3 2025, $30.9 billion in Q3 2024, and $5.3 billion in Q3 2023.